Original paper

The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine

Volume: 148, Issue: 3, Pages: 567 - 572
Published: Sep 1, 2010
Abstract
Background Cardiopulmonary bypass results in ischemia/reperfusion (I/R)-induced endotoxemia. We conducted a prospective randomized trial to investigate the effect of taurolidine, an antiendotoxin agent with antioxidant and membrane-stabilizing properties, on patients undergoing coronary artery bypass grafting (CABG). Methods A total of 60 patients undergoing CABG were randomized into 4 groups. St Thomas' Hospital cold crystalloid cardioplegia...
Paper Details
Title
The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine
Published Date
Sep 1, 2010
Journal
Volume
148
Issue
3
Pages
567 - 572
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.